Cholecystitis and Diabetes Mellitus
Overview
Authors
Affiliations
A real-world disproportionality analysis of semaglutide: Post-marketing pharmacovigilance data.
Du Y, Zhang M, Wang Z, Hu M, Xie D, Wang X J Diabetes Investig. 2024; 15(10):1422-1433.
PMID: 38943656 PMC: 11442840. DOI: 10.1111/jdi.14229.
Prevalence of gallbladder disease in diabetes mellitus.
Chapman B, Wilson I, Frampton C, Chisholm R, Stewart N, Eagar G Dig Dis Sci. 1996; 41(11):2222-8.
PMID: 8943976 DOI: 10.1007/BF02071404.
Faigel D, Metz D Dig Dis Sci. 1996; 41(1):1-8.
PMID: 8565740 DOI: 10.1007/BF02208576.
Del Favero G, Caroli A, Meggiato T, Volpi A, Scalon P, Puglisi A Dig Dis Sci. 1994; 39(8):1704-7.
PMID: 8050321 DOI: 10.1007/BF02087780.
Gastrointestinal manifestations of diabetic ketoacidosis.
Barrett E, Sherwin R Yale J Biol Med. 1983; 56(3):175-8.
PMID: 6419481 PMC: 2589676.